Evidence map›Paper›PMID 39131628›Full record

ArticleBioactive materials2024

Tailored endothelialization enabled by engineered endothelial cell vesicles accelerates remodeling of small-diameter vascular grafts.

Zihao Wang, Mengxue Zhou, Mengyu Li, Jinyu Li, Shengmin Zhang, Jianglin Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioactive materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihao WangDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Mengxue ZhouDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Mengyu LiDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Jinyu LiDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Shengmin ZhangDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Jianglin WangDepartment of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current gold standard for the replacement of small-diameter blood vessel (ID < 4 mm) is still to utilize the autologous vessels of patients due to the limitations of small-diameter vascular grafts (SDVG) on weak endothelialization, intimal hyperplasia and low patency. Herein, we create the SDVG with the tailored endothelialization by applying the engineered endothelial cell vesicles to camouflaging vascular grafts for the enhancement of vascular remodeling. The engineered endothelial cell vesicles were modified with azide groups (ECVs-N

Indexed as

Click chemistryEndothelial cell vesiclesSmall-diameter vascular graftsTailored endothelializationVascular remodeling

Identifiers

PMID39131628
PMCPMC11314893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.